Many patients with metastatic cancers receive therapy that is initially highly effective, often resulting in complete remission. However, cancer cells have a remarkable capacity to evolve resistance ...
An international team of researchers from Trinity College Dublin and the Moffitt Cancer Center in the US has demonstrated a landmark “evolutionary double-bind” strategy to overcome treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results